Stay updated on Daratumumab in NKTCL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in NKTCL Clinical Trial page.

Latest updates to the Daratumumab in NKTCL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.1%

- Check56 days agoChange DetectedPublication notes were updated to indicate automatic filling from PubMed. The revision version information was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the government funding lapse notice (informational banner about operating status) from the page; this non-critical banner does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedThe new screenshot reflects minor UI adjustments such as spacing and header alignment, with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check107 days agoChange DetectedThe page now shows the new revision v3.2.0 and removes the old v3.0.2. This is an update to the release/version information.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in NKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in NKTCL Clinical Trial page.